Hailat, M.; Al-Ani, I.; Zakareia, Z.; Al-Shdefat, R.; Al-Meanazel, O.; Anwer, M.K.; Hamad, M.; Abu Rayyan, W.; Awad, R.; Abu Dayyih, W.
Development and Validation of HPLC-DAD Method for the Determination of Favipiravir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favipiravir. Separations 2022, 9, 303.
https://doi.org/10.3390/separations9100303
AMA Style
Hailat M, Al-Ani I, Zakareia Z, Al-Shdefat R, Al-Meanazel O, Anwer MK, Hamad M, Abu Rayyan W, Awad R, Abu Dayyih W.
Development and Validation of HPLC-DAD Method for the Determination of Favipiravir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favipiravir. Separations. 2022; 9(10):303.
https://doi.org/10.3390/separations9100303
Chicago/Turabian Style
Hailat, Mohammad, Israa Al-Ani, Zainab Zakareia, Ramadan Al-Shdefat, Osaid Al-Meanazel, Md. Khalid Anwer, Mohammed Hamad, Walid Abu Rayyan, Riad Awad, and Wael Abu Dayyih.
2022. "Development and Validation of HPLC-DAD Method for the Determination of Favipiravir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favipiravir" Separations 9, no. 10: 303.
https://doi.org/10.3390/separations9100303
APA Style
Hailat, M., Al-Ani, I., Zakareia, Z., Al-Shdefat, R., Al-Meanazel, O., Anwer, M. K., Hamad, M., Abu Rayyan, W., Awad, R., & Abu Dayyih, W.
(2022). Development and Validation of HPLC-DAD Method for the Determination of Favipiravir and Studying the Impact of Vitamin C on the Pharmacokinetics of COVID-19 Antiviral Drug Favipiravir. Separations, 9(10), 303.
https://doi.org/10.3390/separations9100303